Search

everythinglearnresearchcommunity

for

Search:↓

All hair removal methods irritate underarm skin and cause dryness, with shaving being less irritating but more drying than plucking or waxing.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Ift20 is essential for hair follicle function and skin cell movement.

Quetiapine may cause hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Researchers created a reliable method to detect hair-growth substances in products.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Dutasteride is more effective than finasteride for hair loss treatment.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

A new compound effectively inhibits human 5α-reductase 1.

Skin conditions can signal heart issues, highlighting the need for integrated care.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.